Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jan;260(1):105-14.
doi: 10.1007/s00415-012-6597-0. Epub 2012 Jul 8.

Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study

Maurizio Zibetti  1 , Aristide Merola, Valeria Ricchi, Alice Marchisio, Carlo Alberto Artusi, Laura Rizzi, Elisa Montanaro, Dario Reggio, Claudio De Angelis, Mario Rizzone, Leonardo Lopiano
Affiliations

Long-term duodenal levodopa infusion in Parkinson's disease: a 3-year motor and cognitive follow-up study

Maurizio Zibetti et al. J Neurol. 2013 Jan.

Abstract

Duodenal infusion of levodopa/carbidopa gel (Duodopa) is an effective treatment option for advanced Parkinson's disease (PD). Long-term clinical experience up to 16 years suggests that the safety of this procedure is acceptable, while several observational studies showed that Duodopa reduces motor fluctuations and dyskinesias improving patients' quality of life (QoL). The aim of this study is to investigate the long-term motor and cognitive outcome of Duodopa treatment in advanced PD patients and its' impact on the QoL. Twenty-five consecutive PD patients were assessed using the Unified PD rating scale (UPDRS), a battery of neuropsychological tests, and the PD questionnaire (PDQ-39) at baseline and after a mean period of three years of Duodopa treatment. Seventeen out of 25 patients reached the follow-up evaluation; five patients discontinued Duodopa and three patients died of causes unrelated to drug infusion. Duodopa improved motor complications (UPDRS-IV) and quality of life (PDQ-39). A sub-group of subjects (41 %) developed a significant deterioration of cognitive functions over time. The most common adverse events were dislocation and the kinking of the intestinal tube. In conclusion, Duodopa therapy is effective in the long-term treatment of advanced PD patients. Continuous enteral levodopa infusion achieves a reduction of motor fluctuations and dyskinesias improving patients' QoL, despite the progression of PD motor symptoms and a significant decline in cognitive functions in a sub-group of patients.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. J Neurol. 2002 Feb;249(2):138-45 - PubMed
    1. Clin Neuropharmacol. 2003 May-Jun;26(3):156-63 - PubMed
    1. Ital J Neurol Sci. 1995 Apr;16(3):177-84 - PubMed
    1. Clin Neuropharmacol. 2008 Mar-Apr;31(2):63-73 - PubMed
    1. Neurodegener Dis. 2008;5(3-4):244-6 - PubMed

MeSH terms

LinkOut - more resources